title: A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.
abstract: A series of 1,8-naphthyridine derivatives (12-36), bearing a phenyl group in position 2 and various substituents in positions 4 and 7, were synthesized in an attempt to obtain potent, selective antagonists for the A1 adenosine receptor subtype. The compounds were tested to evaluate their affinity for A1 compared with A2A and A3 adenosine receptor subtypes. In binding studies in bovine brain cortical membranes, most of the compounds showed an affinity for A1 receptors in the low nanomolar range and two in the subnanomolar range with an interesting degree of A1 versus A2A and A3 selectivity. Comparison of the 4-substituted derivatives indicated that 4-OH substitution, with a 4-quinoid structure, causes an increase in the A1 and A2A affinity and generally also in A1 selectivity. The kind of substitution in position 7 can greatly modulate the affinity: the most interesting substituents in this position seemed to be electron-withdrawing groups; in particular the 7-chloronaphthyridine 25d showed a remarkable selectivity (A2A/A1 ratio of 670, A3/A1 ratio of 14,000) associated with a higher A1 affinity (Ki = 0.15 nM). NMR studies on these compounds 12-36 indicated that the 4-OH-substituted ones prefer the tautomer in which the oxygen in position 4 is in the quinoid form and the nitrogen in position 1 is protonated. Theoretical calculations are in agreement with the NMR data.
authors.affiliation: Dipartimento di Scienze Farmaceutiche, Università di Pisa, Italy. ferrarini@farm.unipi.it
authors.forename: P L
authors.initials: PL
authors.lastname: Ferrarini
authors.forename: C
authors.initials: C
authors.lastname: Mori
authors.forename: C
authors.initials: C
authors.lastname: Manera
authors.forename: A
authors.initials: A
authors.lastname: Martinelli
authors.forename: F
authors.initials: F
authors.lastname: Mori
authors.forename: G
authors.initials: G
authors.lastname: Saccomanni
authors.forename: P L
authors.initials: PL
authors.lastname: Barili
authors.forename: L
authors.initials: L
authors.lastname: Betti
authors.forename: G
authors.initials: G
authors.lastname: Giannaccini
authors.forename: L
authors.initials: L
authors.lastname: Trincavelli
authors.forename: A
authors.initials: A
authors.lastname: Lucacchini
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002417:Cattle; D002540:Cerebral Cortex / Q000201:enzymology; D003342:Corpus Striatum / Q000378:metabolism; D066298:In Vitro Techniques; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009287:Naphthyridines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D058915:Purinergic P1 Receptor Antagonists; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D043705:Receptor, Adenosine A2A; D043684:Receptor, Adenosine A3; D013329:Structure-Activity Relationship
chemical_list: D009287:Naphthyridines; D058915:Purinergic P1 Receptor Antagonists; D043705:Receptor, Adenosine A2A; D043684:Receptor, Adenosine A3; D000262:Adenylyl Cyclases